The end of the line? A case of drug resistance to third-line antiretroviral therapy

od Rossouw, Theresa M., Hitchcock, Sonia, Botes, Mariëtte
izdano v South Afr J HIV Med (2016)

Clinical and Pharmacogenetic Factors Affecting Neonatal Bilirubinemia Following Atazanavir Treatment of Mothers During Pregnancy

od Eley, Timothy, Huang, Shu-Pang, Conradie, Francesca, Zorrilla, Carmen D., Josipovic, Deirdre, Botes, Mariëtte, Osiyemi, Olayemi, Hardy, Hélène, Bertz, Richard, McGrath, Donnie
Izdano 2013

Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findings

od Cooper, David A., Heera, Jayvant, Ive, Prudence, Botes, Mariette, Dejesus, Edwin, Burnside, Robert, Clumeck, Nathan, Walmsley, Sharon, Lazzarin, Adriano, Mukwaya, Geoffrey, Saag, Michael, van Der Ryst, Elna
Izdano 2014

Cohort Profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) Monitoring Studies to Evaluate Resistance—HIV drug resistance in sub-Saharan Africa and the Asia-Paci...

od Hamers, Raph L, Oyomopito, Rebecca, Kityo, Cissy, Phanuphak, Praphan, Siwale, Margaret, Sungkanuparph, Somnuek, Conradie, Francesca, Kumarasamy, Nagalingeswaran, Botes, Mariette E, Sirisanthana, Thira, Abdallah, Saade, Li, Patrick C K, Ngorima, Nicoletta, Kantipong, Pacharee, Osibogun, Akin, Lee, Christopher K C, Stevens, Wendy S, Kamarulzaman, Adeeba, Derdelinckx, Inge, Chen, Yi-Ming Arthur, Schuurman, Rob, van Vugt, Michèle, Rinke de Wit, Tobias F
Izdano 2012